Novel mechanism whereby nuclear factor κB mediates DNA damage repair through regulation of O6-methylguanine-DNA-methyltransferase

Cancer Research

Volumn 67, Issue 18, 2007, Pages 8952-8959

  Lavon, Iris ^a,b,c   Fuchs, Dana ^a,b   Zrihan, Daniel ^a,b   Efroni, Gilat ^a,b   Zelikovitch, Bracha ^a,b   Fellig, Yakov ^b   Siegal, Tali ^a,b  

^a Leslie and Michael Gaffin Center for Neuro Oncology Ein Karem   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

6 O BENZYLGUANINE; ALKYLATING AGENT; CARMUSTINE; CRYSTAL VIOLET; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; NITROSOUREA;

ARTICLE; BINDING SITE; CELL STRAIN HEK293; CONTROLLED STUDY; DNA DAMAGE; DNA METHYLATION; DNA REPAIR; DRUG RESISTANCE; GEL MOBILITY SHIFT ASSAY; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; STATISTICAL ANALYSIS;

BASE SEQUENCE; BINDING SITES; CELL LINE, TUMOR; DNA DAMAGE; DNA METHYLATION; DNA MODIFICATION METHYLASES; DNA REPAIR; DNA REPAIR ENZYMES; GENES, REPORTER; GLIOMA; HUMANS; MOLECULAR SEQUENCE DATA; NF-KAPPA B; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; TRANSCRIPTION FACTOR RELA; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

EID: 34548791853     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-3820     Document Type: Article

References (39)

1. Ghosh S, May MJ, Kopp EB. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998;16:225-60.
2. Senftleben U, Karin M. The IKK/NF-κB pathway. Crit Care Med 2002;30:S18-26.
3. Weaver KD, Yeyeodu S, Cusack JC, Jr., et al. Potentiation of chemotherapeutic agents following antagonism of nuclear factor κB in human gliomas. J Neurooncol 2003;61:187-96.
4. 6-benzylguanine or 1,3-bis(2-chloroethyl)-1-nitrosourea. Biochemistry 1996;35:1328-34.
5. 6-Methylguanine-DNA methyltransferase in human normal and tumor tissue from brain, lung, and ovary. Cancer Res 1991;51: 4131-4.
6. 6-methylguanine in DNA in inbred mice. Mech Ageing Dev 1989;48: 43-52.
7. Hegi ME, Diserens AC, Gorlia T, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 2005;352:997-1003.
8. Danam RP, Howell SR, Remack JS, Brent TP. Heterogeneous methylation of the O(6)-methylguanine-DNA methyltransferase promoter in immortalized IMR90 cell lines. Int J Oncol 2001;18:1187-93.
9. 6-methylguanine-DNA methyltransferase in histologically normal brain adjacent to primary human brain tumors. Proc Natl Acad Sci U S A 1996;93: 6941-6.
10. 6-alkylguanine-DNA alkyltransferase. Cancer Res 1989;49: 6044-51.
11. 6- Alkylguanine-DNA alkyltransferase and sensitivity to procarbazine in human brain-tumor xenografts. J Neurosurg 1989;70:573-7.
12. 6-methylguanine-DNA methyltransferase in a DNA excision repair-deficient Chinese hamster ovary cell line and its response to certain alkylating agents. Cancer Res 1992;52:32-5.
13. 6-Methylguanine- DNA methyltransferase in human brain tumors detected by activity assay and monoclonal antibodies. Oncol Res 1995;7:49-55.
14. 6-methylguanine-DNA methyltransferase in the resistance of pancreatic tumors to DNA alkylating agents. Cancer Res 1997;57:5360-8.
15. 6-methylguanine-DNA methyltransferase levels with survival of malignant astrocytoma patients treated with bis-chloroethylnitrosourea: a Southwest Oncology Group study. J Clin Oncol 1998; 16:3310-5.
16. Esteller M, Garcia-Foncillas J, Andion E, et al. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 2000;343:1350-4.
17. 6-benzylguanine for patients undergoing surgery for malignant glioma. J Clin Oncol 1998;16: 3570-5.
18. 6-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents. Cancer Res 1991;51:3367-72.
19. 6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents. Proc Natl Acad Sci U S A 1990;87:5368-72.
20. 6-methylguanine-DNA methyltransferase gene. Nucleic Acids Res 1991;19: 6163-7.
21. 6-methylguanine-DNA methyltransferase gene by glucocorticoid hormone. Oncogene 1999;18: 525-32.
22. 6-methylguanine-DNA methyltransferase via protein kinase C-mediated signaling. Cancer Res 1998;58:3950-6.
23. Amit S, Ben-Neriah Y. NF-κB activation in cancer: a challenge for ubiquitination- and proteasome-based therapeutic approach. Semin Cancer Biol 2003;13: 15-28.
24. Baldwin AS. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB. J Clin Invest 2001;107:241-6.
25. 6-methylguanine-DNA methyltransferase in various uterine cervical lesions. J Cancer Res Clin Oncol 2005;131:364-70.
26. 6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas. Clin Cancer Res 2005;11:5167-74.
27. Janssens S, Tschopp J. Signals from within: the DNA-damage-induced NF-κB response. Cell Death Differ 2006;13:773-84.
28. Wu ZH, Mabb A, Miyamoto S. PIDD: a switch hitter. Cell 2005;123:980-2.
29. Bartek J, Lukas J. Cell biology. The stress of finding NEMO. Science 2006;311:1110-1.
30. Wu ZH, Shi Y, Tibbetts RS, Miyamoto S. Molecular linkage between the kinase ATM and NF-κB signaling in response to genotoxic stimuli. Science 2006;311:1141-6.
31. 6-alkylating agents in human glioblastomas. J Clin Oncol 2006;24: 274-87.
32. 6-methylguanine DNA methyltransferase (MGMT) CpG island is associated with heterochromatinization of the MGMT transcription start site and silencing of the gene. Mol Cell Biol 1997; 17:5612-9.
33. 6-methylguanine DNA methyltransferase gene is associated with the loss of nucleosome-like positioning. Mol Cell Biol 1997;17: 5813-22.
34. 6-methylguanine DNA methyltransferase gene in human glioma cell lines. Mol Cell Biol 1994;14:6515-21.
35. 6-alkylguanine-DNA alkyltransferase. Carcinogenesis 2003;24:625-35.
36. 6-Methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells. J Neurochem 2006;96:766-76.
37. 6- Methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort. J Clin Oncol 2006;24:3431-7.
38. Orlowski RZ, Baldwin AS, Jr. NF-κB as a therapeutic target in cancer. Trends Mol Med 2002;8:385-9.
39. Karin M, Yamamoto Y, Wang QM. The IKK NF-κB system: a treasure trove for drug development. Nat Rev Drug Discov 2004;3:17-26.